Skip to content

Guardant Health GH Operating Income

Operating Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$30.7M-5.9%
NeoGenomics logo
NeoGenomicsNEO
-$9.77M+79.5%
Illumina logo
IlluminaILMN
$209M+27.4%
Veracyte logo
VeracyteVCYT
$22.65M+680%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$6.2M+32.1%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
-$19.21M+35.1%

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$19.04B+255%
Enterprise value$19.65B+229%
P/S17.6×+11.2×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardant Health's operating income?
Guardant Health (GH) reported operating income of -$121.35M in Q1 2026.
How has Guardant Health's operating income changed year-over-year?
Guardant Health's operating income decreased by 9.3% year-over-year, from -$111.04M to -$121.35M.
What is the long-term trend for Guardant Health's operating income?
Over 4 years (2021 to 2025), Guardant Health's operating income has grown at a 1.6% compound annual growth rate (CAGR), from -$411M to -$437.25M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.